Shares of LogicBio Therapeutics Inc. LOGC, +644.44% skyrocketed more than seven-fold (up 643%) in morning trading, to bounce off the previous session’s record low, after the genetic medicine com...
Shares of LogicBio Therapeutics Inc. LOGC, +644.44% skyrocketed more than seven-fold (up 643%) in morning trading, to bounce off the previous session’s record low, after the genetic medicine com...